Hamasaki, Yuko http://orcid.org/0000-0002-2015-9073
Hashimoto, Junya
Aoki, Yujiro
Kubota, Mai
Muramatsu, Masaki
Kawamura, Takeshi
Shishido, Seiichiro
Sakai, Ken
Article History
Received: 30 December 2020
Accepted: 5 November 2021
First Online: 6 January 2022
Declarations
:
: Yuko Hamasaki belongs to an endowed department sponsored by Asahi Kasei Pharma Corporation, Novartis Pharma K.K., Chugai Pharmaceutical Co., and Astellas Pharma (until 28/Feb/2018). Ken Sakai received annual consultant fees from JMS Co. Ltd. The other authors have no potential conflicts of interest to disclose.
: The study protocol conformed to the Declaration of Helsinki (2008) and was approved by the Toho University Omori Medical Center institutional ethics committees (approval number M 20058).